Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection

Antihypertensive therapy can lower the risk of cardiovascular morbidity and mortality. Yet, partly because of inadequate dosing, wrong pharmacological choices, and poor patient adherence, hypertension control remains suboptimal in the majority of hypertensive patients. Achieving greater blood pressu...

Descripción completa

Detalles Bibliográficos
Autores principales: Galzerano, Domenico, Capogrosso, Cristina, Di Michele, Sara, Bobbio, Emanuele, Paparello, Paola, Gaudio, Carlo
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922309/
https://www.ncbi.nlm.nih.gov/pubmed/20730064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922309/
https://www.ncbi.nlm.nih.gov/pubmed/20730064

Ejemplares similares